These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19182460)

  • 1. Functional imaging in mild cognitive impairment and early Alzheimer's disease: is it pertinent?
    Ibáñez V; Deiber MP
    Front Neurol Neurosci; 2009; 24():30-38. PubMed ID: 19182460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neuroimaging in mild cognitive impairment.
    Matsuda H
    Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical discussion of the role of neuroimaging in mild cognitive impairment.
    Wolf H; Jelic V; Gertz HJ; Nordberg A; Julin P; Wahlund LO
    Acta Neurol Scand Suppl; 2003; 179():52-76. PubMed ID: 12603252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroimaging in Alzheimer's disease: an overview].
    Masdeu J
    Rev Neurol; 2004 Jun 16-30; 38(12):1156-65. PubMed ID: 15229831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
    Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease.
    Rinne JO; Någren K
    J Alzheimers Dis; 2010; 19(1):291-300. PubMed ID: 20061645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [At the boundary between normal aging and Alzheimer disease].
    Chételat G; Desgranges B; de la Sayette V; Viader F; Eustache F
    Rev Neurol (Paris); 2004 Apr; 160(4 Pt 2):S55-63. PubMed ID: 15118553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of Alzheimer dementia based on clinical and biological factors.
    Almkvist O; Winblad B
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():3-9. PubMed ID: 10654093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
    Celsis P
    Ann Med; 2000 Feb; 32(1):6-14. PubMed ID: 10711572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
    Román G; Pascual B
    Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.